COVID safety measures still essential even as U.S. boosts vaccine supply: White House
Reuters
Published Mar 03, 2021 11:54AM ET
Updated Mar 03, 2021 12:11PM ET
By Carl O'Donnell and Jarrett Renshaw
NEW YORK (Reuters) - U.S. states need to "rally together" to maintain safety measures like social distancing and mask-wearing even as the federal government helps ramp up the production and delivery of vaccines, the White House said on Wednesday.
White House senior adviser Andy Slavitt said the federal government is planning to spend $100 million to help the joint partnership between Merck & Co and rival Johnson & Johnson (NYSE:JNJ) accelerate vaccine production.
The infusion will help Johnson & Johnson ramp up its production of vaccines, Slavitt said. The company was contracted to deliver 200 million doses to the federal government by the end of May and roughly a billion doses globally by end-2021.
"Over time we believe Merck will be able to double the capacity of Johnson & Johnson," Slavitt said.
Slavitt said while the increased production is good news, he urged states like Texas to reconsider recent decisions to lift mask mandates and allow businesses to fully open without restrictions.
There are health officials in every state who feel "now is the wrong time to lift the mask mandate," Slavitt said. "Hopefully, the country will continue to rally together on this front."
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.